| KRN5500, a novel antitumor agent, induces apoptosis or cell differentiation in HL-60 cells. | |
| | |
MedLine Citation:
|
PMID: 10685078 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: KRN5500, a derivative of spicamycin, shows antitumor activity against a variety of tumor cell lines. However, the mechanism of cytotoxic action has remained unclear. METHODS: The viability of HL-60 human leukemic cells treated with KRN5500 was studied by the dye exclusion assay. Induction of apoptosis and effects on the cell cycle were investigated by flow cytometry: We measured cellular DNA content after extraction of fragmented DNA, and apoptosis-induced DNA strand breaks. Cell morphology was observed by light microscopy. DNA strand breaks at a nucleosomal unit were analyzed by electrophoresis. RESULTS: Our data demonstrated that KRN5500 caused inhibition of cell growth, and that apoptosis was the mode of cell death. G(1) phase cells were more susceptible to KRN5500 induced apoptosis. In addition, KRN5500 induced cell differentiation at lower concentration. CONCLUSIONS: It is anticipated that KRN5500 will be used clinically as an anti-leukemic agent. Its mechanism of antitumor action is to induce apoptosis or cell differentiation. |
| | |
Authors:
|
K Kawasaki; T Murakami; M Ita; K Sasaki; S Furukawa |
Related Documents
:
|
15711178 - Ef24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-... 10822278 - Morphological and molecular evidence of differentiation during etoposide-induced apopto... 12767528 - Enhanced mtt-reducing activity under growth inhibition by resveratrol in cem-c7h2 lymph... 15027128 - Flavaglines: a group of efficient growth inhibitors block cell cycle progression and in... 18550808 - The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of schwann cell d... 17712648 - Ultrastructural alterations in human decidua in miscarriages compared to normal pregnan... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Cytometry Volume: 39 ISSN: 0196-4763 ISO Abbreviation: Cytometry Publication Date: 2000 Mar |
Date Detail:
|
Created Date: 2000-04-05 Completed Date: 2000-04-05 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8102328 Medline TA: Cytometry Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 211-6 Citation Subset: IM |
Copyright Information:
|
Copyright 2000 Wiley-Liss, Inc. |
Affiliation:
|
Department of Pediatrics, Yamaguchi University School of Medicine, Ube, Japan. kozok@d2.dion.ne.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antibiotics, Antineoplastic
/
toxicity* Apoptosis / drug effects* Cell Differentiation / drug effects* Cell Survival / drug effects Cells, Cultured DNA, Neoplasm / isolation & purification Flow Cytometry / methods HL-60 Cells Humans Kinetics Lymphocytes / cytology, drug effects* Purine Nucleosides / toxicity Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Antibiotics, Antineoplastic; 0/DNA, Neoplasm; 0/KRN 5500; 0/Purine Nucleosides |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Staining of mitochondrial membranes with 10-nonyl acridine orange, MitoFluor Green, and MitoTracker ...
Next Document: A novel deep red/low infrared fluorescent flow cytometric probe, DRAQ5NO, for the discrimination of ...